Citation 75740

CHEN,IS: CHANG,CT: SHEEN,WS: TENG,CM: TSAI,IL: DUH,CY: KO,FN:. (1996). COUMARINS AND ANTIPLATELET AGGREGATION CONSTITUENTS FROM FORMOSAN PEUCEDANUM JAPONICUM.. 41(2)

Citation Details

Title	COUMARINS AND ANTIPLATELET AGGREGATION CONSTITUENTS FROM FORMOSAN PEUCEDANUM JAPONICUM.
Authors	CHEN,IS: CHANG,CT: SHEEN,WS: TENG,CM: TSAI,IL: DUH,CY: KO,FN:
Year	1996
Volume	41
Issue	2

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Peucedanum japonicum (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	IMPERATORIN,ISO:	None
4	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PSORALEN	None
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSORALEN	ACTIVE
6	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSORALEN	ACTIVE
7	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSORALEN	ACTIVE
8	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSORALEN	ACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BERGAPTEN	None
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	XANTHOTOXOL	None
11	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EUGENIN	None
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CNIDILIN	None
13	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERGAPTEN	ACTIVE
14	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERGAPTEN	ACTIVE
15	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERGAPTEN	ACTIVE
16	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERGAPTEN	ACTIVE
17	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CNIDILIN	INACTIVE
18	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CNIDILIN	ACTIVE
19	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CNIDILIN	ACTIVE
20	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CNIDILIN	ACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SELINIDIN,(-):	None
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DELTOIN,(-):	None
23	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELINIDIN,(-):	INACTIVE
24	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELINIDIN,(-):	ACTIVE
25	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELINIDIN,(-):	ACTIVE
26	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SELINIDIN,(-):	ACTIVE
27	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	PTERYXIN,(+):	None
28	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	PEUCEDANOCOUMARIN III,(+):	None
29	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERYXIN,(+):	INACTIVE
30	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERYXIN,(+):	ACTIVE
31	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERYXIN,(+):	ACTIVE
32	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERYXIN,(+):	ACTIVE
33	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANOCOUMARIN III,(+):	ACTIVE
34	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANOCOUMARIN III,(+):	ACTIVE
35	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANOCOUMARIN III,(+):	ACTIVE
36	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANOCOUMARIN III,(+):	ACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	XANTHOTOXIN	None
38	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	IMPERATORIN	None
39	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOTOXINIMPERATORIN	ACTIVE
40	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOTOXINIMPERATORIN	ACTIVE
41	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOTOXINIMPERATORIN	ACTIVE
42	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOTOXINIMPERATORIN	ACTIVE
43	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HAMAUDOL,(-):	None
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VISAMMINOL,(+):	None
45	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VISAMMINOL,(+):	INACTIVE
46	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VISAMMINOL,(+):	ACTIVE
47	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VISAMMINOL,(+):	ACTIVE
48	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VISAMMINOL,(+):	INACTIVE
49	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MARMESIN,(+):	None
50	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PEUCEDANIN,OXY: HYDRATE (+):	None
51	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PEUCEDANOL,(+):	None
52	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KHELLACTONE,TRANS: 3'-ACETYL-4'-SENECIOYL: (-):	None
53	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KHELLACTONE,CIS: 3'-ACETYL-4'-TIGLOYL: (DL):	None
54	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KHELLACTONE,CIS: 4'-TIGLOYL: (DL):	None
55	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: 3'-ACETYL-4'-TIGLOYL: (DL):	ACTIVE
56	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: 3'-ACETYL-4'-TIGLOYL: (DL):	ACTIVE
57	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: 3'-ACETYL-4'-TIGLOYL: (DL):	ACTIVE
58	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: 3'-ACETYL-4'-TIGLOYL: (DL):	ACTIVE
59	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: 4'-TIGLOYL: (DL):	INACTIVE
60	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: 4'-TIGLOYL: (DL):	INACTIVE
61	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: 4'-TIGLOYL: (DL):	ACTIVE
62	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,CIS: 4'-TIGLOYL: (DL):	ACTIVE
63	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KHELLACTONE,TRANS: 4'-TIGLOYL: (+):	None
64	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,TRANS: 4'-TIGLOYL: (+):	ACTIVE
65	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,TRANS: 4'-TIGLOYL: (+):	ACTIVE
66	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,TRANS: 4'-TIGLOYL: (+):	ACTIVE
67	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KHELLACTONE,TRANS: 4'-TIGLOYL: (+):	ACTIVE

Citation 75740

Citation Details

Summary

Organisms and Their Experiments (1)

Peucedanum japonicum (APIACEAE)

Show SPARQL Queries (1)

Query 1